Abbott Laboratories (ABT)

R&D Expenses

$3.16B

TTM · Period ending: · USD

ABT logo

ABT R&D Expenses

Latest reported$3.16B
ABT R&D Expenses ($0.00 → $3.16B)
High-resolution chart · PNG

ABT r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
2,955,000,000
2,823,000,000
2,719,000,000
2,852,000,000
2,738,000,000
2,418,000,000
2,408,000,000
2,288,000,000
2,130,000,000
1,358,000,000
1,369,000,000
1,286,000,000
1,371,000,000
1,544,000,000
4,060,414,000
3,572,424,000
2,743,733,000
2,688,811,000
2,402,649,000
2,226,271,000
1,811,175,000
1,696,753,000
1,733,472,000
1,561,792,000
1,577,552,000
1,351,024,000
1,193,963,000
1,221,593,000
1,302,403,000
1,204,841,000
1,072,745,000
963,516,000
880,974,000
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.